Co-authored publications

Olivier Elemento, PhD and Manik Uppal · 6 publications

CSV Word

Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
OEOlivier ElementoMUManik UppalBBBhavneet BhinderARAndrew R MardersteinLMLorenzo M. Falchi+9 more →
PMID: 42054619DOI5 citations
Immunogenomic Landscape of Neuroendocrine Prostate Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
OEOlivier ElementoMUManik UppalASAndrea Sboner JMJuan Miguel Mosquera HBHimisha Beltran
PMID: 37223924PMCID: PMC10524949DOI41 citations
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.
Blood cancer discovery · 2023
OEOlivier ElementoMUManik UppalJZJenny Zhaoying Xiang ECEthel Cesarman+1 more →LGLisa Giulino Roth
PMID: 36723991PMCID: PMC10150291DOI54 citations
The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer.
Cancer research · 2023
OEOlivier ElementoMUManik UppalWLWeisi LiuFKFrancesca Khani+2 more →BMBishoy Morris Faltas
PMID: 36480186DOI30 citations
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial.
The Lancet. Oncology · 2021
OEOlivier ElementoMUManik UppalNKNasser K Altorki TETimothy E. McGraw+11 more →SCSilvia Chiara Formenti
PMID: 34015311DOI325 citations
Demographic and genetic factors influence the abundance of infiltrating immune cells in human tissues.
Nature communications · 2020
OEOlivier ElementoMUManik UppalARAndrew R MardersteinAVAkanksha VermaZTZakieh Tayyebi+1 more →
PMID: 32371927PMCID: PMC7200670DOI32 citations